USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025
A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market
24-Oct-2018
North America
Market Research
PA1F-01-00-00-00
HC03097-NA-MT_22471
$4,950.00
Special Price $3,712.50 save 25 %
The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents an overview of the global cell therapy landscape, with emphasis on the key trends and growth opportunities shaping the market. It highlights the emerging business models supporting the development and manufacture of these novel therapies.
Due to the dynamic market landscape, Big pharma/bio-pharma players are looking to adopt a collaborative business approach by either signing co-development/ co-commercialization agreements or acquiring smaller niche players to gain a competitive advantage with respect to specific therapy areas or technology. The study also highlights some of the innovative payment models that will enhance patient access to these high-value therapies. In addition to the above-mentioned strategic analysis, the emerging business models of risk sharing and fast to market are also examined.
The study aims to identify some of the key growth opportunities for the next few years. It presents revenue analysis of the global cell therapy market at global and regional levels. It presents some of the key market drivers and restraints that affect growth. Additionally, it gives an insight into the leading future trends shaping the global market and their long-term implications. There is also focus on the regulatory challenges faced by disruptive players in terms of market expansion or supporting drug development across emerging markets including China and South Korea.
Key Issues Addressed
- How has the market for cell therapies evolved over the years? What is the future market potential?
- What are the most promising segments? Which segment is attracting the most interest in terms of funding and innovation?
- What are the current and future trends impacting the cell therapy market growth? What emerging business models are set to transform the market landscape?
- What are some of the key regulatory challenges affecting the cell therapy market?
- Who are the key participants making an impact on this market?
- What are the market gaps that need to be addressed and are drawing new entrants?
Purpose of this Experiential Study
5-Step Process to Transformational Growth
Scope and Segmentation
Key Takeaways—How is this Market Important to You?
Market Segmentation—Next Wave of Cell Therapy
Key Findings
Market Engineering Measurements
8 Big Market Themes
Methodology
Executive Summary—Market Snapshot
Cell Therapy Value Chain—Sample Collection to Therapy Infusion Cycle
Paradigm Shift to Chronic Disease Therapies
Stem Cell versus Non-Stem Cell—Regional Highlights
Competitive Landscape—Marketed Products
Competitive Landscape—Pipeline Products*
Overall Pipeline Breakdown
Potential Game Changing Therapies
Drivers and Restraints
Industry Challenges
Market Engineering Measurements
Revenue Forecast
Competitive Playbook—Key Market Participants by Region
Lifecycle Assessment of Leading Cell Therapy Markets
Market Assessment
Market Assessment—The United States
Market Assessment—The United Kingdom
Market Assessment—Germany
Market Assessment—Japan
Market Assessment—China
Market Assessment—South Korea
Competitive Landscape
Emerging Business Models in the Cell Therapy Market
Case Study 1—Novartis’ Acquisition of Avexis
Case Study 2—MaSTherCell and Zelluna Manufacturing Collaboration
Case Study 3—Celgene’s Co-development Partnership with Bluebird Bio
Pitfalls to Avoid
Cell Therapy Market—Macro to Micro Visioning
Key Future Trends Impacting the Market
Alternative Payment Models—Why are they Required?
Payment Models across Cell Therapy Market
Key Mergers & Acquisitions and Partnerships
Technology-focused
Therapeutic-focused Collaborations
Commercialization-focused Collaborations
Top Predictions for the Cell Therapy Market
Transformation in Industry Ecosystem
Strategic Imperatives for Growth
5 Major Growth Opportunities
Growth Opportunity Matrix
Growth Opportunity 1—Curative Combination Therapies
Growth Opportunity 2—Diverse Therapeutic Focus
Growth Opportunity 3—Gaining Expertise through Collaborative Business Approach
Growth Opportunity 4—Genome Editing with CRISPR/Cas9
Growth Opportunity 5—Reducing Time to Market through Manufacturing Automation
The Last Word
Legal Disclaimer
Abbreviations
Definitions—Cell Therapy and Stem Cell Therapy
Regenerative Medicine Industry—Key Stakeholders
Key Mergers & Acquisitions and Partnerships
List of Exhibits
List of Figures
- 1. Total Cell Therapy Market: Overall Pipeline Breakdown, Global, 2017
- 2. Total Cell Therapy Market: Overall Breakdown by Promising Indications, Global, 2017
- 3. Total Cell Therapy Market: Potential Market Launches, Global, 2017
- 4. Total Cell Therapy Market: Drivers and Restraints, Global, 2018–2025
- 5. Total Cell Therapy Market: Market Engineering Measurements, Global, 2017
- 6. Total Cell Therapy Market: Market Assessment, Global, 2017
- 7. Total Cell Therapy Market: Key Mergers & Acquisitions and Partnerships, Global, 2017–2018
- 8. Total Cell Therapy Market: Key Mergers & Acquisitions and Partnerships, Global, 2017
List of Charts
- 1. Total Cell Therapy Market: Segmentation, Global, 2017
- 2. Total Cell Therapy Market: Market Engineering Measurements, Global, 2017
- 3. Total Cell Therapy Market: Marketed Products, Percent Breakdown, Global, 2017
- 4. Total Cell Therapy Market: Pipeline Products*, Percent Breakdown, Global, 2017
- 5. Total Cell Therapy Market: Stem Cell vs. Non-Stem Cell – Regional Highlights, Global, 2017
- 6. Total Cell Therapy Market: Outstanding Marketed Products by Therapeutic Area, Global, 2017
- 7. Total Cell Therapy Market: Products in Development by Therapeutic Area, Global, 2017
- 8. Total Cell Therapy Market: Regional Market Share* (Adoption), Global, 2017
- 9. Total Cell Therapy Market: Revenue Forecast, Global, 2017–2020–2025
- 10. Total Cell Therapy Market: Country-wise Players, Global, 2017
- 11. Total Cell Therapy Market: Growth Opportunity Matrix, Global, 2017
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Key Issues Addressed
- How has the market for cell therapies evolved over the years? What is the future market potential?
- What are the most promising segments? Which segment is attracting the most interest in terms of funding and innovation?
- What are the current and future trends impacting the cell therapy market growth? What emerging business models are set to transform the market landscape?
- What are some of the key regulatory challenges affecting the cell therapy market?
- Who are the key participants making an impact on this market?
- What are the market gaps that need to be addressed and are drawing new entrants?
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Table of Contents | | Executive Dashboard~ || Purpose of this Experiential Study~ || 5-Step Process to Transformational Growth~ || Scope and Segmentation~ || Key Takeaways—How is this Market Important to You?~ || Market Segmentation—Next Wave of Cell Therapy~ || Key Findings~ || Market Engineering Measurements~ || 8 Big Market Themes~ | Growth Environment—Market Overview~ || Methodology~ || Executive Summary—Market Snapshot~ || Cell Therapy Value Chain—Sample Collection to Therapy Infusion Cycle~ || Paradigm Shift to Chronic Disease Therapies~ || Stem Cell versus Non-Stem Cell—Regional Highlights~ || Competitive Landscape—Marketed Products~ || Competitive Landscape—Pipeline Products*~ || Overall Pipeline Breakdown~ || Potential Game Changing Therapies~ || Drivers and Restraints~ || Industry Challenges~ | Growth Environment—Market Forecasts~ || Market Engineering Measurements~ || Revenue Forecast~ | Growth Environment—Competitive Playbook~ || Competitive Playbook—Key Market Participants by Region~ || Lifecycle Assessment of Leading Cell Therapy Markets~ || Market Assessment~ || Market Assessment—The United States~ || Market Assessment—The United Kingdom~ || Market Assessment—Germany~ || Market Assessment—Japan~ || Market Assessment—China~ || Market Assessment—South Korea~ || Competitive Landscape~ || Emerging Business Models in the Cell Therapy Market~ || Case Study 1—Novartis’ Acquisition of Avexis~ || Case Study 2—MaSTherCell and Zelluna Manufacturing Collaboration~ || Case Study 3—Celgene’s Co-development Partnership with Bluebird Bio~ || Pitfalls to Avoid~ | Visioning Scenarios~ || Cell Therapy Market—Macro to Micro Visioning~ || Key Future Trends Impacting the Market~ || Alternative Payment Models—Why are they Required?~ || Payment Models across Cell Therapy Market~ || Key Mergers & Acquisitions and Partnerships~ || Technology-focused~ || Therapeutic-focused Collaborations~ || Commercialization-focused Collaborations~ || Top Predictions for the Cell Therapy Market~ | Growth Opportunities and Companies to Action~ || Transformation in Industry Ecosystem~ || Strategic Imperatives for Growth~ || 5 Major Growth Opportunities~ || Growth Opportunity Matrix~ || Growth Opportunity 1—Curative Combination Therapies~ || Growth Opportunity 2—Diverse Therapeutic Focus~ || Growth Opportunity 3—Gaining Expertise through Collaborative Business Approach~ || Growth Opportunity 4—Genome Editing with CRISPR/Cas9~ || Growth Opportunity 5—Reducing Time to Market through Manufacturing Automation~ | Conclusion~ || The Last Word~ || Legal Disclaimer~ | Appendix~ || Abbreviations~ || Definitions—Cell Therapy and Stem Cell Therapy~ || Regenerative Medicine Industry—Key Stakeholders~ || Key Mergers & Acquisitions and Partnerships~ || List of Exhibits~ |
| List of Charts and Figures | 1. Total Cell Therapy Market: Overall Pipeline Breakdown, Global, 2017~ 2. Total Cell Therapy Market: Overall Breakdown by Promising Indications, Global, 2017~ 3. Total Cell Therapy Market: Potential Market Launches, Global, 2017~ 4. Total Cell Therapy Market: Drivers and Restraints, Global, 2018–2025~ 5. Total Cell Therapy Market: Market Engineering Measurements, Global, 2017~ 6. Total Cell Therapy Market: Market Assessment, Global, 2017~ 7. Total Cell Therapy Market: Key Mergers & Acquisitions and Partnerships, Global, 2017–2018~ 8. Total Cell Therapy Market: Key Mergers & Acquisitions and Partnerships, Global, 2017~| 1. Total Cell Therapy Market: Segmentation, Global, 2017~ 2. Total Cell Therapy Market: Market Engineering Measurements, Global, 2017~ 3. Total Cell Therapy Market: Marketed Products, Percent Breakdown, Global, 2017~ 4. Total Cell Therapy Market: Pipeline Products*, Percent Breakdown, Global, 2017~ 5. Total Cell Therapy Market: Stem Cell vs. Non-Stem Cell – Regional Highlights, Global, 2017~ 6. Total Cell Therapy Market: Outstanding Marketed Products by Therapeutic Area, Global, 2017~ 7. Total Cell Therapy Market: Products in Development by Therapeutic Area, Global, 2017~ 8. Total Cell Therapy Market: Regional Market Share* (Adoption), Global, 2017~ 9. Total Cell Therapy Market: Revenue Forecast, Global, 2017–2020–2025~ 10. Total Cell Therapy Market: Country-wise Players, Global, 2017~ 11. Total Cell Therapy Market: Growth Opportunity Matrix, Global, 2017~ |
| Author | Aarti Chitale |
| Industries | Healthcare |
| WIP Number | PA1F-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9A06-B1,9571-B1,99C0-B1,99C1-B1,9568-B1,9611-B1 |
